<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 32-year old woman with <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome (APS) developed severe <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:hpo ids='HP_0002910'>elevated liver enzymes</z:hpo> and progressive <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> a few days after <z:hpo ids='HP_0001622'>preterm delivery</z:hpo> by caesarean section </plain></SENT>
<SENT sid="1" pm="."><plain>Her condition deteriorated despite treatment with low dose aspirin, anticoagulation by <z:chebi fb="5" ids="28304">heparin</z:chebi> and iv <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> administration </plain></SENT>
<SENT sid="2" pm="."><plain>Intravenous immunoglobulin (IVIG) on three consecutive days was followed by rapid resolution of her neurological impairment and increasing platelets counts </plain></SENT>
<SENT sid="3" pm="."><plain>The temporal association between IVIG and reversal of both neurological impairment and platelet number strongly indicates a specific effect of IVIG administration in this condition </plain></SENT>
<SENT sid="4" pm="."><plain>It is proposed that IVIG therapy is considered as a therapeutic option in APS patients with progressive <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> despite optimal use of <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and immunomodulating agents </plain></SENT>
</text></document>